CORTLANDT MANOR, N.Y., Feb. 20, 2025 /PRNewswire/ -- A recent study published in the JAMA Network Open demonstrates that annual FIT testing is more effective than both triannual blood-based tests and ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved ...